1. Home
  2. SOPH vs NPCE Comparison

SOPH vs NPCE Comparison

Compare SOPH & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SOPHiA GENETICS SA

SOPH

SOPHiA GENETICS SA

HOLD

Current Price

$6.85

Market Cap

462.3M

Sector

Health Care

ML Signal

HOLD

Logo Neuropace Inc.

NPCE

Neuropace Inc.

HOLD

Current Price

$13.88

Market Cap

537.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOPH
NPCE
Founded
2011
1997
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
462.3M
537.0M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
SOPH
NPCE
Price
$6.85
$13.88
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$7.50
$18.33
AVG Volume (30 Days)
294.5K
192.0K
Earning Date
05-05-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
29.03
EPS
N/A
N/A
Revenue
N/A
$99,986,000.00
Revenue This Year
$23.09
$0.90
Revenue Next Year
$19.57
$24.46
P/E Ratio
N/A
N/A
Revenue Growth
N/A
25.13
52 Week Low
$2.97
$7.56
52 Week High
$6.77
$19.60

Technical Indicators

Market Signals
Indicator
SOPH
NPCE
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
SOPH
NPCE

About SOPH SOPHiA GENETICS SA

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.

About NPCE Neuropace Inc.

NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.

Share on Social Networks: